Florida advises against mRNA

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=vFWWuB7qi74

Based on the high rate of global immunity and currently available data, • the State Surgeon General advises against the use of mRNA COVID-19 vaccines. • • Staying physically active, • • • Minimizing processed foods, • • • Prioritizing vegetables and healthy fats, and • • Spending time outdoors to support necessary vitamin D levels. • Florida Department of Health, 12th September 2024 • https://content.govdelivery.com/accou... • Updated Guidance for COVID-19 Boosters for the Fall and Winter 2024–2025 Season • The Florida Department of Health is reminding health care providers of the importance of remaining up to date with current literature related to COVID 19 vaccines and boosters, • and the importance of providing patients with informed consent. • • On August 22, 2024, the United States Food and Drug Administration (FDA) approved and authorized updated versions of mRNA vaccines from Pfizer-BioNtech and Moderna. • https://www.fda.gov/news-events/press... • The FDA approved the vaccine for people 12 and older and provided emergency use authorization for children 6 months to 11 years old. • • Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated, authorized Moderna COVID-19 Vaccine. • The stated target of these boosters is the Omicron variant which is not causing a significant number of infections. • https://publichealth.jhu.edu/2024/wha... • The most recent booster approval was granted in the absence of booster-specific clinical trial data performed in humans. • Furthermore, this booster does not protect against the currently dominant strain, accounting for approximately 37% of infections in the United States. • Florida references FDA again, • https://covid.cdc.gov/covid-data-trac... • There are currently limited data to inform whether these boosters offer any substantial protection against the virus and subsequent circulating variants. • https://www.idsociety.org/covid-19-re... • Although randomized clinical trials are normally used to approve therapeutics, • the federal government has not required COVID-19 vaccine manufacturers to demonstrate their boosters prevent hospitalizations or death from COVID-19 illness. • • Additionally, the federal government has failed to provide sufficient data to support the safety and efficacy of COVID-19 boosters, • or acknowledge previously demonstrated safety concerns associated with COVID-19 vaccines and boosters, including: • • • prolonged circulation of mRNA and spike protein in some vaccine recipients, • • • increased risk of lower respiratory tract infections, and • • • increased risk of autoimmune disease after vaccination. • Health care providers are encouraged to share information in this guidance in discussions with patients regarding the mRNA COVID-19 vaccines and boosters. • Based on the high rate of global immunity and currently available data, • the State Surgeon General advises against the use of mRNA COVID-19 vaccines. • Any provider concerned about the health risks associated with COVID-19 for patients over the age of 65 or with underlying health conditions should prioritize patient access to non-mRNA COVID-19 vaccines and treatment. • Safety and Efficacy Concerns • Providers and patients should be aware of • outstanding mRNA COVID-19 vaccine safety and efficacy concerns: • • The mRNA COVID-19 vaccines present a risk of subclinical and clinical myocarditis and other cardiovascular conditions among otherwise healthy individuals. • https://onlinelibrary.wiley.com/doi/1... • https://www.mdpi.com/2414-6366/7/8/19... • • The mRNA COVID-19 vaccine may be associated with an increased risk of postural orthostatic tachycardia syndrome (POTS). • https://www.nature.com/articles/s4416... • • The mRNA COVID-19 vaccine may be associated with an increased risk of autoimmune diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis, and psoriasis. • https://www.nature.com/articles/s4146...

#############################

New on site